Boston Scientific reports strong Q4 2024 results, forecasts robust 2025 outlook driven by innovative products and robust demand for cardiology devices.
Nissan and Honda's merger talks near collapse due to disagreements over Nissan becoming a Honda subsidiary.
Ransomware payments decline amid global crackdown and victim resistance to paying ransoms.
Boston Scientific reports strong Q4 2024 results, forecasts robust 2025 outlook driven by innovative products and robust demand for cardiology devices.
Nissan and Honda's merger talks near collapse due to disagreements over Nissan becoming a Honda subsidiary.
Ransomware payments decline amid global crackdown and victim resistance to paying ransoms.